Page 2 - Morphosys Papiere Linked News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Morphosys papiere linked. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Morphosys Papiere Linked Today - Breaking & Trending Today

Wells Fargo & Company Reaffirms Overweight Rating for MorphoSys (NASDAQ:MOR)

Wells Fargo & Company reaffirmed their overweight rating on shares of MorphoSys (NASDAQ:MOR – Free Report) in a report issued on Monday, Benzinga reports. They currently have a $17.00 price objective on the stock. Several other analysts also recently commented on MOR. Leerink Partnrs restated a market perform rating on shares of MorphoSys in a […] ....

United States , Leerink Partnrs , Wells Fargo Company , Sigma Securities , Qube Research Technologies Ltd , Jpmorgan Chase Co , Morphosys Company Profile , Virtu Financial , Morgan Stanley , Goldman Sachs Group , Wells Fargo , Free Report , Moderate Buy , Get Free Report , Technologies Ltd , Two Sigma Securities , Morphosys Daily , Nasdaq Mor , Reiterated Rating ,

MorphoSys Shares Jump After It Agrees to $2.9 Bln Takeover by Novartis

By Adria Calatayud MorphoSys shares jumped after the German biotechnology company agreed to be taken over by Swiss pharmaceutical giant Novartis in an. ....

Adria Calatayud , Article Normal , Biotechnology Services , Healthcare Life Sciences , Financial Performance , Share Price Movement Disruptions , Ownership Changes , Acquisitions Mergers Shareholdings , Acquisitions Mergers , Corporate Actions , Corporate Industrial News , Content Types , Factiva Filters , C Amp Ampe Exclusion Filter , C Amp Ampe Industry News Filter , Mor Xe , Xe Mor , Novn Eb , Ch Novn , Share Price Movement , Industrial News , Life Sciences ,

Novartis to acquire cancer-focused MorphoSys for $2.9 billion

Reuters first reported on Monday that Switzerland-based Novartis was in advanced talks to acquire MorphoSys, leading to the German biotech firm's shares surging more than 40%. The Swiss group will offer shareholders 68.00 euros per share in cash and take MorphoSys private after the deal, which is contingent on certain conditions, including a minimum acceptance threshold of 65% of MorphoSys' share capital and regulatory clearances, the companies said. ....

Shilpi Majumdar , Urvi Dugar , Novarti Jakavi , Pratik Jain , Drugmaker Novartis , Switzerland Based Novartis , Constellation Pharma , Rashmi Aich , Louise Heavens , Cancer Treatments ,

Palantir, BP, Eli Lilly, Coherent, Chegg, Spotify, and More Stock Market Movers

Palantir stock surges after the software company posts better-than-expected fourth-quarter revenue growth, while Eli Lilly’s earnings beat estimates. ....

Jerome Powell , York Stock Exchange , Federal Reserve , New York Stock Exchange , Federal Reserve Chairman Jerome Powell , Article Normal , Biotechnology Services , Agricultural Machinery , Computers Consumer Electronics , Applications Software , Life Insurance , Multimedia Content Services , Healthcare Life Sciences , Educational Services , Aerospace Defense , Business Consumer Services , Defense Equipment Products , Media Content Distribution , Enterprise Management Software , Financial Services , Industrial Goods , Online Service Providers , Knowledge Management Software , Media Entertainment , Streaming Services , Financial Performance ,

Novartis to take over MorphoSys in EUR 2.7bn deal, shares jump

Webfg. Story body ....

Shreeram Aradhye , R2 7bn , Category All , Category Market Report , Category Company News , Category News And Announcements , Category International Companies , Category Tecnologia , Category Market Pulse , Category Sectorial Health Technology , Mostread Technology , Mostread Company News ,